Literature DB >> 20028825

Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.

Matthias A Fügi1, Sergio Wittlin, Yuxiang Dong, Jonathan L Vennerstrom.   

Abstract

Peroxidic antimalarials such as the semisynthetic artemisinins are critically important in the treatment of drug-resistant malaria. Nevertheless, their peroxide bond-dependent mode of action is still not well understood. Using combination experiments with cultured Plasmodium falciparum cells, we investigated the interactions of the nitroxide radical spin trap, 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO), and four of its analogs with artemisinin and the ozonide drug development candidate OZ277. The antagonism observed for combinations of artemisinin or OZ277 with the TEMPO analogs supports the hypothesis that the formation of carbon-centered radicals is critical for the activity of these two antimalarial peroxides. The TEMPO analogs showed a trend toward greater antagonism with artemisinin than they did with OZ277, an observation that can be explained by the greater tendency of artemisinin-derived carbon-centered radicals to undergo internal self-quenching reactions, resulting in a lower proportion of radicals available for subsequent chemical reactions such as the alkylation of heme and parasite proteins. In a further mechanistic experiment, we tested both artemisinin and OZ277 in combination with their nonperoxidic analogs. The latter had no effect on the antimalarial activities of the former. These data indicate that the antimalarial properties of peroxides do not derive from reversible interactions with parasite targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028825      PMCID: PMC2825978          DOI: 10.1128/AAC.01305-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  A medicinal chemistry perspective on artemisinin and related endoperoxides.

Authors:  Paul M O'Neill; Gary H Posner
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

2.  The antimalarial drug artemisinin alkylates heme in infected mice.

Authors:  Anne Robert; Françoise Benoit-Vical; Catherine Claparols; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

3.  Docking studies of structurally diverse antimalarial drugs targeting PfATP6: no correlation between in silico binding affinity and in vitro antimalarial activity.

Authors:  Fatima Bousejra-El Garah; Jean-Luc Stigliani; Frédéric Coslédan; Bernard Meunier; Anne Robert
Journal:  ChemMedChem       Date:  2009-09       Impact factor: 3.466

Review 4.  Artemisinin: mechanisms of action, resistance and toxicity.

Authors:  Steven R Meshnick
Journal:  Int J Parasitol       Date:  2002-12-04       Impact factor: 3.981

5.  Electronic structure of persistent radicals: nitroxides.

Authors:  Igor Novak; Leslie J Harrison; Branka Kovac; Lawrence M Pratt
Journal:  J Org Chem       Date:  2004-10-29       Impact factor: 4.354

Review 6.  Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action.

Authors:  C W Jefford
Journal:  Curr Med Chem       Date:  2001-12       Impact factor: 4.530

7.  In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.

Authors:  Christopher Snyder; Jacques Chollet; Josefina Santo-Tomas; Christian Scheurer; Sergio Wittlin
Journal:  Exp Parasitol       Date:  2006-11-07       Impact factor: 2.011

8.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

9.  The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.

Authors:  J Bhisutthibhan; X Q Pan; P A Hossler; D J Walker; C A Yowell; J Carlton; J B Dame; S R Meshnick
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum.

Authors:  David A Elliott; Michael T McIntosh; H Dean Hosgood; Shuo Chen; Gina Zhang; Pavlina Baevova; Keith A Joiner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

View more
  26 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties.

Authors:  Jérôme Molette; Julie Routier; Nada Abla; Dominique Besson; Agnes Bombrun; Reto Brun; Howard Burt; Katrin Georgi; Marcel Kaiser; Solomon Nwaka; Mathilde Muzerelle; Alexander Scheer
Journal:  ACS Med Chem Lett       Date:  2013-09-22       Impact factor: 4.345

3.  3-Alkoxy-1,2-Dioxolanes: Synthesis and Evaluation as Potential Antimalarial Agents.

Authors:  Charles E Schiaffo; Matthias Rottman; Sergio Wittlin; Patrick H Dussault
Journal:  ACS Med Chem Lett       Date:  2011-04-14       Impact factor: 4.345

4.  Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts In Vitro Antimalarial Activity.

Authors:  Susan A Charman; Darren J Creek; Carlo Giannangelo; Lukas Stingelin; Tuo Yang; Leann Tilley
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

5.  Investigating the antimalarial action of 1,2,4-trioxolanes with fluorescent chemical probes.

Authors:  Carmony L Hartwig; Erica M W Lauterwasser; Sumit S Mahajan; Jonathan M Hoke; Roland A Cooper; Adam R Renslo
Journal:  J Med Chem       Date:  2011-11-09       Impact factor: 7.446

6.  Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.

Authors:  Susan A Charman; Sarah Arbe-Barnes; Ian C Bathurst; Reto Brun; Michael Campbell; William N Charman; Francis C K Chiu; Jacques Chollet; J Carl Craft; Darren J Creek; Yuxiang Dong; Hugues Matile; Melanie Maurer; Julia Morizzi; Tien Nguyen; Petros Papastogiannidis; Christian Scheurer; David M Shackleford; Kamaraj Sriraghavan; Lukas Stingelin; Yuanqing Tang; Heinrich Urwyler; Xiaofang Wang; Karen L White; Sergio Wittlin; Lin Zhou; Jonathan L Vennerstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

7.  In Vitro Susceptibility of Leishmania infantum to Artemisinin Derivatives and Selected Trioxolanes.

Authors:  Sofia Cortes; Andreia Albuquerque; Lília I L Cabral; Liliana Lopes; Lenea Campino; Maria L S Cristiano
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

8.  Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.

Authors:  Gerald Geroldinger; Matthias Tonner; Judith Quirgst; Martin Walter; Sritama De Sarkar; Laura Machín; Lianet Monzote; Klaus Stolze; J Catharina Duvigneau; Katrin Staniek; Mitali Chatterjee; Lars Gille
Journal:  Biochem Pharmacol       Date:  2019-11-29       Impact factor: 5.858

9.  Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo.

Authors:  Edgar Deu; Ingrid T Chen; Erica M W Lauterwasser; Juan Valderramos; Hao Li; Laura E Edgington; Adam R Renslo; Matthew Bogyo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

10.  Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.

Authors:  Yiping Wang; Rupkatha Mukhopadhyay; Sujayita Roy; Arun Kapoor; Yu-Pin Su; Susan A Charman; Gong Chen; Jianbo Wu; Xiaofang Wang; Jonathan L Vennerstrom; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.